{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Dexketoprofen/Tramadol for Postoperative Pain Management"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "multicentre, randomised, double-blind, double-dummy, placebo- and active-controlled trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "641 patients aged 18\u201380 years were enrolled across 37 sites in 10 countries"
      },
      "Intervention": {
        "score": 2,
        "evidence": "dexketoprofen/tramadol 25 mg/75 mg fixed-dose combination compared to dexketoprofen 25 mg and tramadol 100 mg"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluated the analgesic efficacy and safety of a dexketoprofen/tramadol 25 mg/75 mg fixed-dose combination"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the mean sum of pain intensity differences (SPID) over 8 hours post-dose"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "randomised using an Interactive Voice/Web Response system with allocation concealment"
      },
      "Blinding": {
        "score": 3,
        "evidence": "double-blind, double-dummy"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "641 patients were randomised: 213 to dexketoprofen/tramadol, 214 to dexketoprofen, and 214 to tramadol"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "641 patients were randomised: 213 to dexketoprofen/tramadol, 214 to dexketoprofen, and 214 to tramadol"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The mean SPID 8 values were 247 for dexketoprofen/tramadol, 209 for dexketoprofen, 205 for tramadol, and 151 for placebo. The combination was superior to dexketoprofen (P=0.019) and tramadol (P=0.012)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse drug reactions were low and similar across groups, with 2.8% in the combination group, 4.7% in the dexketoprofen group, and 5.1% in the tramadol group"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: EudraCT 2012-004548-31; ClinicalTrials.gov NCT01902134"
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: Menarini Group"
      }
    },
    "total_score": 24,
    "max_score": 25
  },
  "model": "gpt-4o"
}